Increase/Decrease in Cash: The total change in cash for the company over the given period.
Altimmune, Inc. (ALT) had Increase/Decrease in Cash of $24.31M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.01M |
|
$-19.01M |
|
-- |
|
$0.01M |
|
$20.86M |
|
$-20.86M |
|
$1.84M |
|
$-19.01M |
|
$-19.01M |
|
$-19.01M |
|
$-19.01M |
|
$-19.01M |
|
$-19.01M |
|
$-20.86M |
|
$-20.91M |
|
89.42M |
|
89.42M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$216.62M |
|
$0.34M |
|
$1.83M |
|
$218.45M |
|
$12.61M |
|
$14.45M |
|
$20.24M |
|
$32.85M |
|
$185.60M |
|
$185.60M |
|
$185.60M |
|
95.60M |
|
| Cash Flow Statement Financials | |
$-48.09M |
|
$-53.31M |
|
$125.71M |
|
$36.97M |
|
$61.28M |
|
|
Increase/Decrease in Cash |
$24.31M |
$11.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.18 |
|
-- |
|
-- |
|
0.07 |
|
0.08 |
|
100.00% |
|
-417180.00% |
|
-417180.00% |
|
-- |
|
-380280.00% |
|
-380280.00% |
|
$-48.10M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.00 |
|
0.03M |
|
-10.24% |
|
-10.24% |
|
-8.70% |
|
-9.50% |
|
$1.94 |
|
$-0.54 |
|
$-0.54 |
|